SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-022348
Filing Date
2020-11-24
Accepted
2020-11-23 21:57:59
Documents
76
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1020897
2 ex31-1.htm EX-31.1 13983
3 ex31-2.htm EX-31.2 14181
4 ex32-1.htm EX-32.1 6496
5 ex32-2.htm EX-32.2 6664
6 image_001.jpg GRAPHIC 3883
  Complete submission text file 0001493152-20-022348.txt   4788969

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE mslp-20200630.xml EX-101.INS 804648
8 XBRL SCHEMA FILE mslp-20200630.xsd EX-101.SCH 50321
9 XBRL CALCULATION FILE mslp-20200630_cal.xml EX-101.CAL 74475
10 XBRL DEFINITION FILE mslp-20200630_def.xml EX-101.DEF 160745
11 XBRL LABEL FILE mslp-20200630_lab.xml EX-101.LAB 364336
12 XBRL PRESENTATION FILE mslp-20200630_pre.xml EX-101.PRE 285960
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53166 | Film No.: 201339772
SIC: 2834 Pharmaceutical Preparations